Perrigo Company plc

PRGO ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Revenue $4.95B $5.28B $4.23B $3.91B $800.0K $3.17B
Cost of Revenue $2.97B $3.23B $2.58B $2.46B $2.26B $2.08B
Gross Profit $1.98B $2.05B $1.64B $1.45B $1.28B $1.10B
Gross Margin 40.0% 38.9% 38.9% 37.1% 160,000.0% 34.5%
Operating Expenses
Research & Development $167.7M $184.0M $187.8M $152.5M $115.2M $105.8M
SG&A Expense $461.1M $452.2M $385.3M $411.3M $240.2M $224.4M
Operating Income $598.2M $-2.00B $672.5M $571.4M $679.1M $569.2M
Operating Margin 12.1% -37.9% 15.9% 14.6% 84,887.5% 17.9%
Interest Expense
Pretax Income $280.1M $-4.85B $260.3M $303.6M $607.7M $512.0M
Income Tax Expense $160.5M $-835.5M $124.2M $70.8M $165.8M $119.0M
Net Income $119.6M $-4.01B $136.1M $232.8M $441.9M $401.6M
Net Margin 2.4% -76.0% 3.2% 5.9% 55,237.5% 12.7%
EPS (Basic) $0.84 $-28.01 $0.97 $2.02 $4.71 $4.31
EPS (Diluted) $0.84 $-28.01 $0.97 $2.01 $4.68 $4.27
Shares Outstanding (Basic) 142.3M 143.3M 139.3M 115.1M 93.9M 93.2M
Shares Outstanding (Diluted) 142.6M 143.3M 139.8M 115.6M 94.5M 94.1M
Dividends Per Share $0.64 $0.58 $0.46 $0.39 $0.35 $0.31
← Newer Page 2 of 2 Older →